Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
Posted on: Monday, 16 March 2009, 07:00 CDT
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
The Medical Technologies & Life Sciences Awards are given to companies that have made a significant contribution to the pharmaceutical, biotech, drug discovery, clinical diagnostics, medical imaging, and medical device industries. Such companies have shown success at meeting the needs of patients and other stakeholders in the healthcare industry, while building world-class companies with strong management teams.
The evening will feature a CEO Roundtable session titled, "CEO Insights: Healthcare and Life Sciences Growth Leadership Panel," in which five senior-level executives will discuss how they have been able to address challenges and still realize growth.
"The Award recipients are pioneers in the industry," explains Frost & Sullivan's Director of Healthcare Research
To choose Award recipients, Frost & Sullivan's healthcare analyst team tracks emerging and existing markets and evaluates the contributions of industry participants. Analysts quantify several market factors for each participant according to predetermined criteria that define innovation in medical technologies and life sciences. The analysts also consider the pace of technology development and deployment, and the potential relevance or significance of the innovation to the overall industry. The Award recipient is ultimately chosen after a thorough evaluation of this research.
The Awards banquet will take place from
The Awards banquet will be co-located with 14th Annual Medical Devices 2009: A Frost & Sullivan Executive MindXchange, taking place
Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
Contact: Jake Wengroff 210.247.3806 jake.wengroff@frost.comSOURCE Frost & Sullivan
Source: PR Newswire
Related Articles
- Frost & Sullivan Awards Websense for Product Innovation and Market Leadership
- Lennox International Receives 2009 North American Frost & Sullivan Award for Industry Innovation & Leadership of the Year
- Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
- Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services
- Frost & Sullivan Distinguishes Aeration Industries for Innovation in Wastewater Aeration and Mixing
- Frost & Sullivan Award Underlines Microsoft's Outstanding Innovations in Customer Service in the Automotive Sector
- Accuris Networks Presented With 2006 Frost & Sullivan Award for Product Differentiation Innovation in the European FMC Market
- SPSS Receives Frost & Sullivan Award for Industry Innovation & Advancement in Predictive Analytics
- GE Healthcare Named Frost & Sullivan's 2005 Medical Imaging Company of the Year
- AstraZeneca Receive Highly Coveted Frost & Sullivan Award: 'Pharmaceutical Industry Product of the Year' for Anastrozole (ARIMIDEX(TM))
User Comments (0)

RSS Feeds